LOS ANGELES, CA / ACCESSWIRE / January 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
For any person or company that makes coin by renting property, a tenant default is the situation nightmares are made of. That's only compounded if the landlord in question manages multiple properties and a tenant defaults on more than one of them.
LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIPR" or the "Company") (NYSE:IIPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR). Investors who purchased IIPR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IIPR.
Innovative Industrial Properties: PharmaCann's Default Puts The Dividend At Risk (Rating Downgrade)
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIPR" or the "Company") (NYSE: IIPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR). Investors who purchased IIPR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IIPR.
LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.
IIPR has lost nearly half of its value, thanks to the drastic PharmaCann default on all of its leases announced on December 20, 2024. The deep selloff is unsurprising indeed, given that the largest tenant comprises 17% of the cannabis REIT's rental revenues, as many investors likely feared a similar downward spiral as MPW. Even so, we believe that the correction triggers an excellent buying opportunity, thanks to IIPR's healthy balance sheet, high AFFO payout ratio, and richer dividend yields at 11.4%.
LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innovative Industrial Properties, Inc. ("IIP" or "the Company") (NYSE:IIPR) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.